Edition:
United Kingdom

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

3.78USD
3:41pm GMT
Change (% chg)

$-0.03 (-0.79%)
Prev Close
$3.81
Open
$3.86
Day's High
$3.90
Day's Low
$3.72
Volume
21,221
Avg. Vol
99,723
52-wk High
$10.23
52-wk Low
$3.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.29 -0.549
Jun '18 0.36 -0.595
Mar '18 0.15 -0.683
FY 2017 Dec '17
Sep '17 0.13 -0.706
Jun '17 0.00 -0.739
Mar '17 0.13 -0.805
FY 2016 Dec '16 0.08 -0.737
Sep '16 0.11 -0.657
Jun '16 0.10 -0.613
Mar '16 0.09 -0.561
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 1.19 5.43 0.00 0.06
Quarter Ending Mar-19 2 1.35 2.70 0.00 --
Year Ending Dec-18 5 1.97 6.24 0.60 0.46
Year Ending Dec-19 5 2.82 10.80 0.00 21.58
Earnings (per share)
Quarter Ending Dec-18 5 -0.56 -0.43 -0.73 -0.72
Quarter Ending Mar-19 3 -0.51 -0.41 -0.57 --
Year Ending Dec-18 4 -2.36 -2.26 -2.55 -2.94
Year Ending Dec-19 5 -2.23 -1.60 -3.11 -2.71
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.72 34.40
P/E High - Last 5 Yrs. -- 148.04 46.21
P/E Low - Last 5 Yrs. -- 47.80 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 1,169.61 49.54 6.22
Price to Book (MRQ) 3.08 10.17 5.20
Price to Tangible Book (MRQ) 3.08 13.82 6.74
Price to Cash Flow (TTM) -- 52.81 24.17
% Owned Institutions 57.02 3.75 1.77

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 129.94 8.17
Sales (TTM) vs TTM 1 Yr. Ago 13.73 47.86 6.50
Sales - 5 Yr. Growth Rate -- 22.77 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -20.53 75.89 23.27
EPS (TTM) vs TTM 1 Yr. Ago -26.74 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.50
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 8.34 3.43 3.10
LT Debt to Equity (MRQ) 22.22 18.73 11.49
Total Debt to Equity (MRQ) 25.02 31.43 16.03
Interest Coverage (TTM) -- -43.28 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.35 54.44
Gross Margin - 5 Yr. Avg. -- 60.59 52.36
EBITD Margin (TTM) -24,512.38 -- --
EBITD - 5 Yr. Avg -- -109.93 13.16
Operating Margin (TTM) -25,442.11 -184.87 6.07
Operating Margin - 5 Yr. Avg. -- -126.36 8.47
Pre-Tax Margin (TTM) -26,033.13 -175.63 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.51 8.71
Net Profit Margin (TTM) -26,033.13 -182.37 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.91 4.90
Effective Tax Rate (TTM) -- 21.48 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.58 23.84

Efficiency

  Company industry sector
Revenue/Employee (TTM) 2,936 7,652,294 873,073,486
Net Income/Employee (TTM) -764,427 652,908 103,486,338
Receivable Turnover (TTM) 0.98 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.00 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.94 6.46 11.45
Return on Assets - 5 Yr. Avg. -- 5.53 12.50
Return on Investment (TTM) -56.99 9.00 14.96
Return on Investment - 5 Yr. Avg. -- 6.86 16.23
Return on Equity (TTM) -67.22 10.14 16.53
Return on Equity - 5 Yr. Avg. -- 8.39 17.37
  1 Year 3 Year 5 Year
Sales % 37.59 -41.53 --
EPS (TTM) % -39.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Bellicum Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.25 9.34 99 98
13 Week -2.82 -7.55 88 94
26 Week -6.65 -13.75 88 98
52 Week -43.96 -52.50 42 68
YTD -16.52 -26.69 59 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.53%
# of Holders: 158
Total Shares Held: 24,944,437
3 Mo. Net Change: -1,314,249
# New Positions: 17
# Closed Positions: 10
# Increased Positions: 59
# Reduced Positions: 50
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.